Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease

Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, April D. Lake and Nathan J. Cherrington
Drug Metabolism and Disposition December 2010, 38 (12) 2293-2301; DOI: https://doi.org/10.1124/dmd.110.035006
Rhiannon N. Hardwick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig D. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Canet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
April D. Lake
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan J. Cherrington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 38 no. 12 2293-2301
DOI 
https://doi.org/10.1124/dmd.110.035006
PubMed 
20805291

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 15, 2010
  • Accepted August 30, 2010
  • Published online November 17, 2010.

Article Versions

  • Earlier version (August 30, 2010 - 06:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Rhiannon N. Hardwick,
  2. Craig D. Fisher,
  3. Mark J. Canet,
  4. April D. Lake and
  5. Nathan J. Cherrington
  1. Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona
  1. Address correspondence to:
    Dr. Nathan J. Cherrington, 1703 E. Mabel St., Tucson, AZ 85721. E-mail: cherrington{at}pharmacy.arizona.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2010 to May 2022

AbstractFullPdf
Aug 2010103021
Oct 2010770114
Nov 2010235665
Dec 20101871722
Jan 20111182136
Feb 20111112128
Mar 20111462229
Apr 2011772117
May 2011681410
Jun 2011511215
Jul 201177811
Aug 2011691619
Sep 2011931811
Oct 2011942012
Nov 201187129
Dec 2011363333
Jan 2012404039
Feb 2012335436
Mar 2012414938
Apr 2012298430
May 2012276743
Jun 2012194833
Jul 2012254223
Aug 2012284421
Sep 2012205929
Oct 2012277830
Nov 2012266728
Dec 2012171214
Jan 2013644121
Feb 2013372618
Mar 2013222016
Apr 2013212519
May 2013321313
Jun 2013122023
Jul 2013161710
Aug 2013141211
Sep 201334107
Oct 201327249
Nov 20137118
Dec 2013101621
Jan 2014132715
Feb 2014181110
Mar 2014231218
Apr 201412174
May 2014181214
Jun 20141757
Jul 201417148
Aug 201411610
Sep 2014111118
Oct 2014864
Nov 201414114
Dec 2014101411
Jan 2015292313
Feb 2015152011
Mar 2015401435
Apr 2015191312
May 2015192319
Jun 201524138
Jul 2015112115
Aug 2015257449
Sep 2015391341
Oct 20157510
Nov 201517912
Dec 201524715
Jan 201627917
Feb 2016131214
Mar 20168915
Apr 20162297
May 2016231912
Jun 201671021
Jul 2016121242
Aug 201610827
Sep 20168178
Oct 201682210
Nov 20166196
Dec 201671910
Jan 201722514
Feb 201742711
Mar 20171247
Apr 20172155
May 20171187
Jun 20171125
Jul 2017779
Aug 20171178
Sep 201722114
Oct 20173199
Nov 201703611
Dec 20174167
Jan 20181325
Feb 201851713
Mar 201841815
Apr 20182246
May 20186258
Jun 20182204
Jul 20183115
Aug 2018395
Sep 20183149
Oct 20184166
Nov 20181195
Dec 2018993
Jan 20191023
Feb 20192127
Mar 20192143
Apr 20193229
May 20191745
Jun 20198211
Jul 20193039
Aug 20193125
Sep 20193211
Oct 20195246
Nov 20193924
Dec 20194823
Jan 20202821
Feb 20201410
Mar 20201521
Apr 20201300
May 20202443
Jun 20202030
Jul 20201411
Aug 2020715
Sep 20203443
Oct 20203533
Nov 20204532
Dec 20204827
Jan 202140236
Feb 202124174
Mar 20212686
Apr 20213823
May 20214432
Jun 202151112
Jul 20212925
Aug 202140147
Sep 20213181
Oct 20212734
Nov 20213655
Dec 20212823
Jan 20223343
Feb 20223932
Mar 20222932
Apr 20223757
May 20222642

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 38 (12)
Drug Metabolism and Disposition
Vol. 38, Issue 12
1 Dec 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease

Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, April D. Lake and Nathan J. Cherrington
Drug Metabolism and Disposition December 1, 2010, 38 (12) 2293-2301; DOI: https://doi.org/10.1124/dmd.110.035006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease

Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, April D. Lake and Nathan J. Cherrington
Drug Metabolism and Disposition December 1, 2010, 38 (12) 2293-2301; DOI: https://doi.org/10.1124/dmd.110.035006
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments.
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics